Achieve life sciences promotes jaime xinos to chief commercial officer to advance commercial readiness of cytisinicline

Seattle and vancouver, british columbia, oct. 16, 2024 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage pharmaceutical company dedicated to the global development and commercialization of cytisinicline for the treatment of nicotine dependence, is pleased to announce the promotion of ms. jaime xinos to chief commercial officer, effective immediately.
ACHV Ratings Summary
ACHV Quant Ranking